The funding round included participation from ArrowMark Partners, Winslow Capital Management, and Conversion Venture Capital (CVC2). The Series C financing marks the beginning of the next chapter in the advancement and optimization of SmartLabs' laboratory solution portfolio, and follows a number of important strategic milestones for the company - including the appointment of industry veteran Brian Taylor as interim CEO earlier this month, and the launch of its new San Francisco-based CleanSuites™ offering and most advanced research center to date in August, 2023 - positioning the company for sustained growth moving forward.

Founded in 2015, SmartLabs offers the first integrated platform combining flexible lab infrastructure, operations, and scientific expertise. Its Managed Research Centers allow companies to purchase private, enterprise-grade R&D infrastructure and manufacturing solutions 'as-a-service' without upfront capital investments. With headquarters in Boston and locations across the U.S., SmartLabs serves over 120 diverse biotech, biopharma and life sciences organizations.